Time-Restricted Eating + High-Intensity Training Aids Women With Obesity, Inactivity
By Lori Solomon HealthDay Reporter
TUESDAY, May 7, 2024 -- Combining time-restricted eating (TRE) with high-intensity functional training (HIFT) may have superior effects on body composition, lipid profile, and glucose regulation among inactive women with obesity compared with diet or exercise interventions alone, according to a study published online May 1 in PLOS ONE.
Ranya Ameur, from University of Sfax in Tunisia, and colleagues examined the long-term effects of TRE, with or without HIFT, on body composition and cardiometabolic biomarkers in women with inactivity and obesity. The analysis included 64 participants randomly assigned to TRE (no more than an eight-hour daily eating window, with ad libitum energy intake), HIFT (three sessions/week), or TRE plus HIFT (TRE-HIFT) for 12 weeks.
The researchers found that TRE-HIFT showed a significantly greater decrease in waist and hip circumferences and fat mass versus TRE or HIFT. Additionally, weight and body mass index significantly decreased more in TRE-HIFT versus HIFT group. The TRE group had lower fat-free mass versus both the HIFT and TRE-HIFT groups. The TRE-HIFT group showed decreases in total cholesterol, triglycerides, insulin, and homeostatic model assessment for insulin resistance versus both the TRE and HIFT groups. Furthermore, glucose level was significantly decreased in the TRE-HIFT group versus the HIFT group. In both the TRE-HIFT and HIFT groups, systolic blood pressure was decreased significantly when compared with the TRE group.
"In inactive women with obesity, combining TRE with HIFT can be a good strategy to induce superior effects on body composition, lipid profile, and glucose regulation compared with either diet or exercise intervention alone," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.